Bristol-Myers Squibb (BMY) Tops Q1 EPS by 1c, Maintains EPS Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.06 +0.35%
EPS Growth %: +5.5%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +5.5%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.10, $0.01 better than the analyst estimate of $1.09. Revenue for the quarter came in at $5.92 billion versus the consensus estimate of $5.76 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.10-$4.20, versus the consensus of $4.19.
- Worldwide revenues increasing in the mid-single digits.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
- Anthropic delays planned IPO from October to November - WSJ
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
